NUS medical school developing Covid-19 vaccine with Monash University

in DLIKElast year


Researchers from the National University of Singapore (NUS) and Monash University in Australia are developing a Covid-19 vaccine that could be ready for clinical trials by the end of next year.

The vaccine, modified from a cancer drug, has undergone animal studies, and researchers are hoping to conduct clinical trials in Singapore and Australia.

Called Clec9A-RBD, it is the third coronavirus vaccine that Singapore is involved in developing.

Shared On DLIKE

Coin Marketplace

STEEM 0.71
TRX 0.10
JST 0.074
BTC 57397.14
ETH 4325.04
BNB 609.29
SBD 6.99